Pheton Holdings Ltd (PTHL): Price to Earnings Adjusted for Growth Rate

Symbol and logo of brand Pheton Holdings Ltd (PTHL)

The young management of Pheton Holdings Ltd (PTHL) is currently building market credibility. The growth stock attractiveness indicator reflects price dynamics relative to business expansion, where 0.00 determines the latest valuation metric. Pheton Holdings Ltd is implementing software to optimize radiation therapy, increasing clinic profitability, and developing targeted thyroid medications for the Chinese market.

PTHL - Pheton Holdings Limited PEG Multiple over the range 09/06/2024 - 01/16/2026

Metric breakdowns and analytics for Pheton Holdings Limited (PTHL)

- share price and consensus valuation forecast:
Fundamental company analysis:Pheton - PTHL
Mass-produced product of Pheton Holdings

Pheton Holdings Ltd (PTHL) relies on external production capacities, making its efficiency dependent on third-party vendors. This PEG growth stock filter compares the P/E market multiple with earnings growth rates. The indicator measures the cost of each unit of growth, eliminating the distortions of a standard P/E. Values below one signal that the asset is undervalued relative to its expansion. This allows for an objective assessment of the company's investment attractiveness.

Competing companies

HLN - Price to Earnings Adjusted for Growth Rate|Price/Earnings to Growth Ratio Kenvue Inc KVUE|Verona Pharma (VRNA) - Price to Earnings Adjusted for Growth Rate|MENS: Price/Earnings to Growth Multiple|Ligand - Company Value to Earnings Growth Ratio|AMRX: PEG Multiple|Perrigo Company - Growth-Adjusted Payback Ratio|ALVO (Alvotech S.A.) - PEG Multiple|Price to Earnings Adjusted for Growth Rate liquidia.com LQDA|Price/Earnings to Growth Ratio Galapagos (GLPG)|ANIP (ANI Pharmaceuticals, Inc.) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Afrezza MNKD|PEG Multiple Amphastar Corp AMPH|Pacira Corp - PEG Multiple|Growth-Adjusted Payback Ratio SPRY (ars-pharma.com)|TBPH: PEG Multiple|Aquestive Therapeutics, Inc. (AQST) - PEG Multiple|SCPH (scpharmaceuticals.com) - PEG Multiple|TECX (tectonictx.com) - Company Value to Earnings Growth Ratio|Price/Earnings to Growth Multiple TNXP (Tonix Pharmaceuticals Holding Corp.)|PEG Multiple SXT China (SXTC)|eupraxiapharma.com - Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio BHST|invizyne.com - PEG Multiple|Growth-Adjusted Payback Ratio ORMP (Oramed Pharmaceuticals Inc.)|ENTX: PEG Multiple|MindWalk Holdings Inc. (HYFT) - PEG Multiple|Price/Earnings to Growth Ratio ABVC BioPharma|Growth-Adjusted P/E Ratio CPIX (Cumberland Pharmaceuticals Inc.)|PEG Multiple QNTM|Growth-Adjusted Market Cap to Net Income FibroGen Corporation|PEG Multiple TELO (Telomir Pharmaceuticals Corp)|RANI (Rani Therapeutics Inc) - Market Cap to Earnings and Growth Ratio|SNYR: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio RLYB (Rallybio)|LEXX: PEG Multiple|Price/Earnings to Growth Multiple Pulmatrix, Inc.|Price/Earnings to Growth Ratio Aptorum Group Limited|LYRA (Lyra Therapeutics, Inc.) - Company Value to Earnings Growth Ratio|PEG Multiple IBO|Growth-Adjusted Market Cap to Net Income TNF Pharmaceuticals, Inc.|PEG Multiple YCBD (cbdMD, Inc.)|PRFX (PainReform Corp) - Market Cap to Earnings and Growth Ratio|CYTO: Price/Earnings to Growth Multiple|LIPO - PEG Multiple|OptiNose, Inc. (OPTN) - Price/Earnings to Growth Ratio|PIRS - Growth-Adjusted Market Cap to Net Income|Price/Earnings to Growth Ratio Procaps|Price/Earnings to Growth Multiple Petros (PTPI)|Price/Earnings to Growth Ratio Qilian International Corp (QLI)|PEG Multiple acelyrin.com (SLRN)|PEG Multiple TFFP (TFF Pharmaceuticals)